T1	Concept 37 43	CVL218
T2	Concept 243 253	SARS-CoV-2
T4	Concept 69 73	lung
R1	in-context Arg1:T1 Arg2:T4	
T5	Concept 13 33	higher distributions
R2	has-property Arg1:T1 Arg2:T5	
T6	Concept 114 121	arbidol
T7	Action 93 101	compared
R3	target Arg1:T7 Arg2:T1	
R4	target Arg1:T7 Arg2:T6	
T3	Action 230 239	treatment
A1	Uncertain T3
R5	subject Arg1:T3 Arg2:T1	
R6	target Arg1:T3 Arg2:T2	
T8	Concept 401 406	CD147
T13	Concept 357 367	SARS-CoV-2
T9	Action 410 422	facilitating
T10	Concept 423 433	SARS-CoV-2
R9	subject Arg1:T9 Arg2:T8	
R10	target Arg1:T9 Arg2:T10	
T14	Concept 318 328	host cells
T15	Concept 486 496	SARS-CoV-2
T16	Action 501 507	invade
A2	Uncertain T16
T17	Concept 512 526	urinary system
T18	Concept 528 548	hematological system
T19	Concept 553 569	digestive system
T20	Concept 585 603	respiratory system
R12	subject Arg1:T16 Arg2:T15	
R13	target Arg1:T16 Arg2:T17	
R14	target Arg1:T16 Arg2:T18	
R15	target Arg1:T16 Arg2:T19	
R16	target Arg1:T16 Arg2:T20	
T21	Concept 447 457	host cells
R17	in-context Arg1:T8 Arg2:T21	
T22	Concept 679 690	salt-bridge
T23	Action 691 708	presented between
A3	Negated T23
R18	subject Arg1:T23 Arg2:T22	
T24	Concept 734 738	E329
T25	Concept 742 746	ACE2
T26	Concept 788 798	SARS-CoV-2
T27	Concept 799 802	RBD
R19	has-part Arg1:T26 Arg2:T27	
R20	has-part Arg1:T25 Arg2:T24	
R21	target Arg1:T23 Arg2:T24	
R22	target Arg1:T23 Arg2:T27	
T11	Concept 305 310	CD147
T12	Action 296 304	blocking
R7	in-context Arg1:T11 Arg2:T14	
R8	target Arg1:T12 Arg2:T11	
T28	Concept 336 346	inhibitory
R23	has-property Arg1:T12 Arg2:T28	
R11	in-context Arg1:T28 Arg2:T13	
T30	Concept 844 853	ritonavir
T31	Concept 858 867	lopinavir
T32	Concept 871 879	COVID-19
T33	Concept 890 909	coronavirus disease
T34	Action 937 947	inhibitory
T35	Concept 958 965	CEP_C30
T36	Concept 1036 1045	darunavir
T37	Concept 1049 1059	SARS-CoV-2
T38	Concept 1143 1147	PLVP
T39	Action 1122 1132	inhibitory
R24	is-a Arg1:T32 Arg2:T33	
T29	Concept 822 840	therapeutic effect
R27	subject Arg1:T34 Arg2:T30	
R28	subject Arg1:T34 Arg2:T31	
R29	target Arg1:T34 Arg2:T35	
R25	has-property Arg1:T34 Arg2:T29	
R26	in-context Arg1:T29 Arg2:T33	
R30	subject Arg1:T39 Arg2:T36	
R31	target Arg1:T39 Arg2:T38	
T40	Concept 1078 1096	therapeutic effect
R32	has-property Arg1:T39 Arg2:T40	
R33	in-context Arg1:T40 Arg2:T37	
